Outcome of Patients Treated With Extracorporeal Life Support
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiogenic Shock
- Sponsor
- Nanjing Medical University
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- Composite of death from any cause, resuscitated circulatory arrest, and implantation of another mechanical circulatory support device
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.
Investigators
Hong Liu
Investigator of Department of Cardiac Surgery
Nanjing Medical University
Eligibility Criteria
Inclusion Criteria
- •Patients receiving ECMO for circulatory and/or respiratory support
Exclusion Criteria
- •Refusal of consent
Outcomes
Primary Outcomes
Composite of death from any cause, resuscitated circulatory arrest, and implantation of another mechanical circulatory support device
Time Frame: 30 days after ECMO implantation
Secondary Outcomes
- All-cause mortality(12 months after ECMO implantation)